Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Central Nervous System Disease Vaccines
Research reports on central nervous system disease vaccines from Raul Carrea Institute for Neurological Research, Department of Neurology provide new insights
April 23rd, 2008
Investigators publish new data in the report 'Vaccines for multiple sclerosis: progress to date.' According to recent research from Buenos Aires, Argentina, "Multiple sclerosis (MS) is an inflammatory demyelinating disease of the CNS, characterized pathologically by a perivascular infiltrate consisting predominantly of T cells and macrophages. Although its aetiology remains unknown, several lines of evidence support the hypothesis that autoimmune mechanisms play a major role in the development of the disease." "Several widely used disease-modifying agents are approved for the treatment of MS. However, these agents are only partially effective and their ability to...
Source: Vaccine Weekly (2008-04-23)
|
